July 2026
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2026
The global particle therapy market size is expected to increase from USD 1.86 billion in 2025 to hit around USD 3.92 billion by 2035, growing at a CAGR of 7.75%.
July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
July 2026
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 3.20 billion in 2025, with a CAGR of 27.55%.
July 2026
The global radiation therapy market size was estimated at USD 8.15 billion in 2025 and is expected to hit around USD 19.29 billion by 2035 with a CAGR of 9%.
July 2026
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
July 2026
The stem cell therapy market size is expected to increase from USD 18.13 billion in 2025 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
July 2026
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2026
The oncology market size surpassed USD 250.88 billion in 2025 and is expected to hit around USD 732.45 billion by 2035 with a CAGR of 11.31%.
July 2026
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
July 2026
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The global physical therapy market size is estimated to hit around USD 52.53 billion by 2035, increasing from USD 26.04 billion in 2025, with a CAGR of 7.27%.
June 2026
The global photothermal therapy patches market size is anticipated at USD 275.29 million in 2025 and is predicted to hit around USD 560.86 million by 2035, growing at a CAGR of 7.38%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
Oncology proteomics market to grow significantly by 2035, driven by cancer research advances, biomarker discovery, and rising demand for precision medicine.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com